Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
Introduction Estimating the value of providing effective healthcare interventions in a country requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the resources required had, instead, been made available f...
Saved in:
Main Authors: | Jessica Ochalek, James Lomas, Karl Claxton, Kaja Abbas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-10-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/5/10/e003006.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 vaccines pricing policy options for low-income and middle- income countries
by: Javier Guzman, et al.
Published: (2021-03-01) -
Tackling antimicrobial resistance in low-income and middle-income countries
by: Sunil Pokharel, et al.
Published: (2019-12-01) -
Management of neonatal jaundice in low-income and middle-income countries
by: Omer Erdeve
Published: (2020-02-01) -
Impact of measles vaccination strategies on vaccination rates in low-income and middle-income countries: a systematic review and meta-analysis
by: Andrew Hayen, et al.
Published: (2025-02-01) -
A comparative analysis of supply chain factors impacting COVID-19 vaccine security in high-income countries (HICs) and low-income and middle-income countries (LMICs)
by: Jeremy H Veillard, et al.
Published: (2024-11-01)